24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Licensing
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:24
UpScrolled founder denounces “Zionist money” at Web Summit, claims Big Tech enabled genocide in Gaza
19:05
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
18:49
Vietnam to produce Rafael Spike missiles locally in $250 million deal
18:36
Wiz finds major flaw in Moltbook, the vibe-coded social network for AI bots
More stories
Buzz
Most popular
Daily
Weekly
1
Why Apple paid billions for a company with no revenue
2
Valued at $800 million after less than two years, Vega eyes the path blazed by Wiz
3
Israeli startups raise over $1 billion in January, marking best opening month since 2022
4
Google-Wiz deal expected to be cleared by EU following meeting with regulators, report says
5
From secret satellites to civilian services: Israel’s space industry reinvents itself
More news
Licensing
4 stories about Licensing
Israeli roads off-limits to Tesla Cybertruck due to licensing issues
18.07.24
|
Tomer Hadar
Ministry of Transportation holds back approval over bulletproof concerns
“Licensing practices are tilting the market in favor of certain providers against others”
07.05.22
|
James Spiro
Francisco Mingorance, Executive General at CISPE, explains how cloud monopolies are affecting licensing agreements online
Israel to Set Up Fast Track for Licensing Fintech Projects
19.08.19
|
Meir Orbach
According to the Israeli Ministry of Finance, there are currently 2,000 different entities awaiting licensing, many of which are fintech and blockchain companies that need to make only slight adjustments to comply with current regulations
Teva Reaches Confidential Patent Settlement with Neos
27.12.18
|
CTech
The agreement will enable Teva to manufacture and sell a generic version of Neos’ ADHD drug Cotempla as of 2026